VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $132,693 | +49.3% | 4,931 | +67.1% | 0.00% | 0.0% |
Q2 2023 | $88,855 | -6.9% | 2,951 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $95,465 | +12.9% | 2,951 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $84,576 | +41.0% | 2,951 | +18.0% | 0.00% | +100.0% |
Q3 2022 | $60,000 | -11.8% | 2,500 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $68,000 | -29.2% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $96,000 | +20.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $80,000 | +8.1% | 2,500 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $74,000 | +45.1% | 2,500 | +66.7% | 0.00% | 0.0% |
Q2 2021 | $51,000 | +4.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $49,000 | -9.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $54,000 | -8.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $59,000 | +7.3% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $55,000 | +57.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $35,000 | -20.5% | 1,500 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $44,000 | +10.0% | 1,500 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $40,000 | -44.4% | 1,500 | -46.4% | 0.00% | -50.0% |
Q2 2019 | $72,000 | +14.3% | 2,800 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $63,000 | – | 2,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |